Can Acupuncture Treat Post-stroke Depression?
NCT02644161 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 91
Last updated 2019-05-20
Summary
An 8-week, assessor-blind, randomized controlled trial will be conducted. A total of 138 patients with post-stroke depression (PSD) will be randomly assigned to the combination acupuncture treatment (CAI) (n = 69) or least acupuncture stimulation (LAS) (n = 69) for 3 sessions per week for 8 weeks. Treatment outcomes will be measured using the 17-item Hamilton Self-Rating Depression Scale (HAMD-17), the Montgomery-Asberg Depression Rating Scale (MADRS), and Self-Rating Depression Scale (SDS) for depression symptoms; Barthel Index (BI) for physical function, the Montreal Cognitive Assessment (MoCA) for cognitive performance. The assessment will be performed at baseline and once monthly thereafter. The study will be conducted in School of Chinese Medicine Clinics, Tung Wah Hospital, Kowloon Hospital.
Conditions
- Stroke
- Depression
- Stroke Sequelae
Interventions
- PROCEDURE
-
Dense cranial electroacupuncture stimulation
DCEAS is a novel stimulation mode in which electrical stimulation is delivered on acupoints located on the forehead. Six pairs of acupoints are used: Baihui (GV20, +) and Yintang (EX-HN3, -), left Sishencong (EX-HN1, -) and Toulinqi (GB15, +), right Sishencong (EX-HN1, -) and Toulinqi (GB15, +), bilateral Shuaigu (GB8, L+, R-), bilateral Taiyang (EX-HN5, L+, R-), and bilateral Touwei (ST8, L+, R-). Disposable acupuncture needles (Hwato®, 0.30 mm in diameter and 25-40 mm in length) are inserted at a depth of 10-30 mm perpendicularly or obliquely into acupoints. Manual manipulation is then conducted to evoke needling sensation, followed by electrical stimulation (ITO ES-160, continuous waves at 2 Hz, 100 µs).
- PROCEDURE
-
Body acupuncture
Following acupoints are used: Shui-Gou (GV26), Shen-Men (HT7). He-Gu (LI4), Qu-Chi (LI11), Guan-Yuan (CV4), Zu-San-Li (ST36), Feng-Long (ST40) and San-Yin-Jiao (SP6). Disposable acupuncture needles (Hwato®, 0.30 mm in diameter and 25-40 mm in length) are inserted at a depth of 10-30 mm perpendicularly or obliquely into acupoints. Manual manipulation is then conducted to evoke needling sensation at 15 min. No electrical stimulation is delivered.
- DRUG
-
Antidepressant
Patients will continue their existing antidepressant therapy as usual. Treatment regimens may be further adjusted during 8 weeks of study, depending upon physicians' discretion.
- OTHER
-
Rehabilitation
Patients will continue their existing rehabilitation therapy as usual. Treatment regimens may be further adjusted during 8 weeks of study, depending upon physicians' discretion.
- PROCEDURE
-
Least acupuncture stimulation
The acupoints chosen are less related to the treated syndromes based on Traditional Chinese Medicine (TCM) theory; the number of acupoints used and the intensity of electrical stimulation are also lower than the comprehensive acupuncture regimen. The following 6 acupoints will be used in LAS control: bilateral Tong-Tian (BI7, L+, R-), bilateral Shou San-Li (LI10) and bilateral Fu-Yang (BL59). Electrical stimulation will be only performed on bilateral Tong-Tian (BI7) and the intensities are adjusted to a level at which patients just start feeling the stimulation.
Sponsors & Collaborators
-
Tung Wah Hospital
collaborator OTHER -
Kowloon Hospital, Hong Kong
collaborator OTHER -
The University of Hong Kong
lead OTHER
Principal Investigators
-
Zhang-Jin ZHANG, MMed, PhD · School of Chinese Medicine, The University of Hong Kong
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 35 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-10-31
- Primary Completion
- 2018-07-31
- Completion
- 2018-10-31
Countries
- Hong Kong
Study Locations
More Related Trials
-
Construction and Clinical Validation Study of a Prediction Model for Depression After Ischemic Stroke
NCT07294274 ·Status: RECRUITING
-
The Establishment and Analysis of the Clinical Prediction Model of Acupuncture and Moxibustion for Stroke Recovery
NCT03946566 ·Status: UNKNOWN
-
Acupuncture Lowering Blood Pressure for Secondary Prevention of Stroke
NCT02967484 ·Status: UNKNOWN ·Phase: NA
-
Acupuncture Combined With Nimodipine for Prevention of Post-stroke Dementia
NCT06007573 ·Status: COMPLETED ·Phase: NA
-
Lu's Acupuncture and Moxibustion Treatment on Stroke
NCT01806233 ·Status: UNKNOWN ·Phase: NA
-
Scalp Acupuncture for Dyskinesia After Ischemic Stroke
NCT03120650 ·Status: UNKNOWN ·Phase: NA
-
Study on the Effect Mechanism of Acupuncture Combined With Swallowing Training in Oral Dysphagia of Stroke
NCT05982977 ·Status: UNKNOWN ·Phase: NA
-
Electroacupuncture on Modifying Inflammatory Levels of Cytokines and Metabolites in Stroke Patients.
NCT05734976 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Acupuncture in Patients Post-Covid Brain Fog
NCT06144320 ·Status: UNKNOWN ·Phase: NA
-
Clinical Study of Angong Niuhuang Pill and Acupuncture on PSCI Angong Niuhuang Pill Combined With Supervised Pulse Music Electroacupuncture on Cognitive Impairment After Ischemic Stroke
NCT05731310 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Acupuncture Intervention to Improve Neurological Function and Anti-inflammatory Effect in Acute Ischemic Stroke (ANAIS)
NCT03097055 ·Status: COMPLETED ·Phase: NA
-
Effects of Seated Tai Chi on Recovery Among Stroke Survivors
NCT04138407 ·Status: UNKNOWN ·Phase: NA
-
Effect of Specific Mode Electroacupuncture Stimulation Combined with NGF on Dysphagia After Ischaemic Stroke: a Pilot Randomized Controlled Trial
NCT06737549 ·Status: RECRUITING ·Phase: PHASE4
-
the Clinical Effect of TCM Sniffing Therapy Combined With Electroacupuncture in PSCI
NCT06313866 ·Status: RECRUITING ·Phase: NA
-
A Clinical Trail of Acupuncture and Liu-Zi-Jue Exercise for Dysphagia in Post-stroke
NCT04398355 ·Status: UNKNOWN ·Phase: NA
-
Relationship of Nocturnal Concentrations of Melatonin, γ-aminobutyric Acid and Total Antioxidants With Insomnia
NCT03202121 ·Status: UNKNOWN
-
Randomized, Double Blind, Placebo Control Trial to Evaluate the Efficacy of Astragalus Membranaceus in the Patients After Stroke With Fatigue
NCT01554787 ·Status: UNKNOWN ·Phase: PHASE4
-
Prophylactic Effects of Agomelatine for Poststroke Depression
NCT05426304 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Reperfusion Therapy for Minor Ischemic Stroke in China
NCT07322835 ·Status: NOT_YET_RECRUITING
-
Efficacy and Safety of Angong Niuhuang Wan for Stroke
NCT04236427 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Study on the Application of Positive Psychological Counseling Based on "Dou Bao" Software in Patients With Post-stroke Depression
NCT07336888 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Autologous Bone Marrow Mesenchymal Stem Cell Transplantation for Chronic Stroke
NCT01714167 ·Status: UNKNOWN ·Phase: PHASE1
-
Acute Ischemic Apoplexy Syndrome Specificity and Acupuncture Intervention Research
NCT04528472 ·Status: UNKNOWN ·Phase: NA
-
A Clinical Trail of Integrative Medicine Approaches for Post-Stroke Cognitive Impairment
NCT04596072 ·Status: COMPLETED ·Phase: NA
-
Post-stroke Depression Treatment Effect on Stroke Recurrence
NCT04776226 ·Status: COMPLETED ·Phase: NA